Related Experiment Video
Updated: Apr 6, 2026
12:18
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
8.2K
Selected Micronutrients in Cognitive Decline Prevention and Therapy
Francesco Visioli1, Emma Burgos-Ramos2
1Department of Molecular Medicine, University of Padova, Viale G. Colombo 3, 35121, Padova, Italy. francesco.visioli@imdea.org.
Molecular Neurobiology
|July 23, 2015
Summary
As global populations age, neurodegenerative diseases like dementia rise. Dietary micronutrients offer promising strategies for brain aging prevention, especially when treatments are limited.
Area of Science:
- Gerontology and Neuroscience
- Nutritional Science
Background:
- Global population aging is increasing the incidence of age-related neurological conditions, including cognitive decline and dementia.
- Effective treatments for dementia are lacking, highlighting the need for preventative strategies.
- Diet and lifestyle are recognized as crucial factors in preventing neurodegenerative diseases.
Purpose of the Study:
- To review the impact of specific micronutrients on the aging brain.
- To propose dietary interventions for mitigating age-related cognitive decline and dementia risk.
Main Methods:
- Literature review of existing studies on micronutrients and brain aging.
- Analysis of the role of diet in the prevention of neurodegenerative diseases.
Main Results:
- Selected micronutrients demonstrate significant effects on brain aging processes.
- Dietary improvements can be a viable strategy for early-stage dementia prevention.
- Evidence supports the role of nutrition in maintaining cognitive function during aging.
Conclusions:
- Micronutrient intake is critical for supporting brain health in aging populations.
- Proactive dietary strategies can help prevent or delay the onset of age-related cognitive decline and dementia.
- Further research into specific dietary interventions is warranted to combat the growing burden of dementia.
Related Concept Videos
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
869
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
869
01:30Cognitive Development During Adulthood
1.2K
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
1.2K
01:22Alzheimer's Disease: Treatment
1.2K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.2K
01:26Alzheimer's Disease: Overview
2.0K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
2.0K
01:23Role of Neurotransmitters in Memory
2.9K
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
2.9K
01:30Dementia
719
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
719